Newswise — COLUMBUS, Ohio – Timothy P. Cripe, MD, PhD, division chief of Hematology/Oncology & BMT, and Nicholas D. Yeager, MD, oncologist at Nationwide Children’s Hospital, have recently published a book titled, “Malignant Pediatric Bone Tumors – Treatment & Management.”
In addition to providing overall information regarding best practices when diagnosing, treating and managing malignant pediatric bone tumors, the book also offers in depth discussion about chemotherapeutic procedures, radiation therapy, limb-salvage options and amputation-related issues. Additionally, these treatment-focused chapters address the treatment approach to lung nodules, the role of biomarkers, the monitoring of patients who are not in active therapy and treatment options when a relapse occurs.
Other chapters also discuss psychosocial needs, as well as guidance on specific nursing practices during treatment and rehabilitation after orthopedic surgery. Closing chapters provide input on emerging therapies and disparate aspects of survivorship.
Dr. Cripe’s research and clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma, and bone and soft tissue sarcomas. His current research focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies. He was among the first in the country to launch clinical trials of attenuated oncolytic viruses in children.
A physician team member in the Orthopedic Oncology clinic, Dr. Yeager has clinical interests in bone tumors, soft tissue sarcomas and malignancy in adolescents and young adults. Dr. Yeager also serves as director of the Adolescent and Young Adult (AYA) Program at Nationwide Children’s.
In partnership with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Dr. Cripe and Dr. Yeager, faculty members at The Ohio State University College of Medicine, and their teams worked closely with Sarcoma specialists at The James. Additionally, a total of 27 authors from six different institutions contributed to the work.
Copies of the book are available online at SpringerLink and can be read on most mobile reading devices.
RSS